BOSTON, June 24, 2026 (GLOBE NEWSWIRE) -- Labviva, the intelligent procurement platform purpose-built for life sciences R&D, today announced the…
PRINCETON, N.J., June 24, 2026 (GLOBE NEWSWIRE) -- Noom, the leading behavior change company trusted by millions, today announced the…
June 24, 2026 10:00 ET | Source: SoldierStrong STAMFORD, Conn., June 24, 2026 (GLOBE NEWSWIRE) -- SoldierStrong, a national nonprofit…
MONTREAL, June 23, 2026 (GLOBE NEWSWIRE) -- PREMIER HEALTH OF AMERICA INC. (TSX-V: PHA) (“Premier Health” or the “Company”) announces…
MONTREAL, June 23, 2026 (GLOBE NEWSWIRE) -- The Biocodex Microbiota Foundation, an organization founded by Biocodex and dedicated to supporting…
New Chief Medical and Innovation Officer, Senior Vice President of Health Care Economics, and Vice President of Population Health Management…
STOCKHOLM, June 22, 2026 (GLOBE NEWSWIRE) -- A3P Biomedical, a diagnostics company specializing in prostate cancer screening, today announced the…
Inaugural Session to be Held Wednesday, July 1, 2026, at 12:00 p.m. ET Recurring Forum Intended to Increase Transparency, Strengthen…
ROCKVILLE, MD, June 22, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative…
Results from the Phase 3 VELA clinical trials at Week 52 in adults with moderate-to-severe hidradenitis suppurativa (HS) demonstrate sonelokimab’s…